![Thomas Zindrick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Zindrick
Verkställande Direktör på
GENELUX CORPORATION
Förmögenhet: 2 M $ per 2026-05-31
Profil
Thomas D.
Zindrick is Chairman, President & Chief Executive Officer at Genelux Corp.
since 2023 and Executive Vice Chairman at Aeromics, Inc. since 2018.
Former roles include Director at DNX Biopharmaceuticals, Inc. from 2014 to 2020, Director at Amitech Therapeutic Solutions, Inc. from 2014 to 2021, Attorney at The Dow Chemical Co., and Vice President & Associate General Counsel at Amgen, Inc. from 2008 to 2009.
Education includes undergraduate studies at North Central College and graduate studies at the University of Illinois College of Law.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
GENELUX CORP. 1,19 % | 2026-05-11 | 532 051 ( 1,19 % ) | 2 M $ | 2026-05-31 |
Aktiva positioner av Thomas Zindrick
| Företag | Position | Start |
|---|---|---|
| GENELUX CORPORATION | Verkställande Direktör | 2014-05-28 |
Aeromics, Inc.
 Aeromics, Inc. BiotechnologyHealth Technology Operates preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema in stroke | Direktör/Styrelseledamot | 2018-08-16 |
Tidigare kända positioner av Thomas Zindrick
| Företag | Position | Slut |
|---|---|---|
Amitech Therapeutic Solutions, Inc | Verkställande Direktör | 2021-02-01 |
DNX Biopharmaceuticals, Inc.
 DNX Biopharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic proteins for the treatment of patients with life-long diseases | Direktör/Styrelseledamot | 2020-03-01 |
| AMGEN INC. | Compliance Officer | 2008-01-01 |
| DOW CHEMICAL COMPANY (THE) | Företagsledare/Principal | - |
Thomas Zindricks utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
92
Första gradens relationer
8
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 8 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
The Dow Chemical Co.
 The Dow Chemical Co. Chemicals: Major DiversifiedProcess Industries Manufactures specialty additives, modifiers and plastic polyethylene products | Process Industries |
Genelux Corp.
 Genelux Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs and virus strains solutions | Health Technology |
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Operates preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema in stroke | Health Technology |
North Central College
 North Central College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois College of Law
 University of Illinois College of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DNX Biopharmaceuticals, Inc.
DNX Biopharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic proteins for the treatment of patients with life-long diseases | Commercial Services |
Amitech Therapeutic Solutions, Inc |
